LA JOLLA PHARMACEUTICAL COMPANY
10182 Telesis Court, 6th Floor
San Diego, California 92121
December 6, 2016
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: J. Green
Re: La Jolla Pharmaceutical Company, a California corporation (the “Company”)
Registration Statement on Form S-3
File No. 333-214721
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 PM (Eastern Daylight Time) on December 8, 2016, or as soon thereafter as is practicable.
Very truly yours, | ||
La Jolla Pharmaceutical Company | ||
By: | /s/ Dennis M. Mulroy | |
Name: | Dennis M. Mulroy | |
Title: | Chief Financial Officer |